BioInformant

Your Global Leader in Stem Cell Market Research

MENUMENU
  • Blog
    • Interviews
  • News
  • Stem Cells
    • iPS Cells
    • MSCs
    • HSCs
    • Adipose SCs
    • Neural Stem Cells
  • Exosomes
  • CAR-T
  • Cord Blood
  • Shop
    • Products
    • Submit PR
    • Advertise
  • About
    • Testimonials
    • Story
    • Guarantee
    • Contact
  • Home
  • Blog
    • Stem Cells
      • HSCs
      • iPS Cells
      • MSCs
      • Neural Stem Cells
      • Adipose SCs
    • Exosomes
    • Cell Therapy
      • CAR-T
    • Cord Blood
    • Stem Cell News
    • Interviews
  • COVID-19
  • Shop
  • Submit PR
  • Company
    • Advertise
    • Testimonials
    • Story
    • Job Posts
    • Guarantee
    • Privacy Policy
    • Contact
Home » market research » Page 5

3 Most Influential Factors that Cause Stem Cell Researchers to Buy From You Over the Competition

December 28, 2015 By Cade Hildreth (CEO) Leave a Comment

3 Most Influential Factors that Cause Stem Cell Researchers to Buy From You Over the Competition

After being asked repeatedly about this information, we’ve decided to share with you key insights from our recent “Survey of Stem Cell Researchers.”

Previously, we shared with you the Top 5 Providers of Stem Cell Products. Congrats to five companies who made the list.

Today, we’re going to be sharing with you the three most influential factors that cause stem cell researchers to purchase from you over the competition. [Read more…]

Filed Under: Stem Cells Tagged With: market metrics, market research, planning, predictions, product marketing, social analytics

Analysis of Induced Pluripotent Stem Cell (iPSC) Patents

December 24, 2015 By Cade Hildreth (CEO) Leave a Comment

iPSC Patents

The landscape for induced pluripotent stem cell (iPSC or iPS cell) patents has changed substantially over the past 10 years, evolving to be geographically clustered in four specific regions.

As background, groundbreaking experimentation led to the discovery of iPSCs in 2006, which are adult cells that are transformed into embryonic-like stem cells through the manipulation of gene expression or other related methods.  In 2007, follow-up experiments proved human adult cells could be transformed into iPSC cells.

Since the discovery of iPSCs, a large and thriving research product market has grown into existence, largely because the cells are completely non-controversial and can be generated directly from adult cells.

Role of Induced Pluripotent Stem Cell (iPSC) Patent Analysis

Today, the number of iPSC products sold worldwide is increasing with double-digit growth, and 22% of all stem cell researchers self-report having used iPSCs within a research project. It is clear that iPSCs represent a lucrative product market, but  commercializing the cell type involves careful and due diligence, because the cells are still a relatively new discovery.

Because the iPSC industry is a rapidly-evolving area, major research findings and technical discoveries are frequently announced . Therefore, to launch iPSC products and technologies, one of the key areas that company management and investors must consider is the patent landscape for the cell type. [Read more…]

Filed Under: iPS Cells, Stem Cells Tagged With: competitors, iPSC, market research, patent

3 Key Predictions for Market Research in 2016

December 23, 2015 By Cade Hildreth (CEO) Leave a Comment

3 Key Predictions for Market Research in 2016

As 2015 comes to an end and 2016 approaches, our team of stem cell analysts has been discussing how the new year will impact us, our partners, and our clients. As President/CEO of the first and only company specializing in stem cell markets, I spend a lot of time thinking about this topic. After substantial reflection on trends that gained momentum in 2015, I can can state with confidence that I believe the following trends will be major market research forces in 2016.  [Read more…]

Filed Under: Stem Cells Tagged With: market metrics, market research, planning, predictions, social analytics

3D Printing, Stem Cell Manufacturing, Future Directions for iPSCs, and More

November 10, 2015 By Cade Hildreth (CEO) Leave a Comment

3D Printing, Stem Cell Manufacturing, Future Directions for iPSCs, and More

Hey, we’ve posted new content about stem cells and cord blood that I’m excited to share with you. Let me know what you think.


 

How 3D Printing with Stem Cells will Alter the Future of Medicine
Without question, 3D printing is a transformative technology. It is now impacting a diverse range of industries, including medicine, science, technology, manufacturing, and defense. 3D printing is also impacting the stem cell industry, as recent weeks have seen “thaw and use” stem cell ink, 3D printing of iPSCs, and successful blood vessel creation. This article introduces current successes with 3D printing, including 3D printed kidneys and techniques that may speed up by 3D printing by 100, or possibly even 1000, times.

 

Cynata Therapeutics to Test Proprietary MSC Manufacturing Process in GvHD Clinical Trial
Cynata Therapeutics, a stem cell and regenerative medicine company listed on the Australian stock exchange (ASX: CYP), released major news by announcing that mesenchymal stem cells produced using its Cymerus™ manufacturing platform will be utilized in a Phase 1 clinical study involving patients with steroid-refractory GvHD. The Clinical Trial Company Ltd was identified as the contract research organization (CRO) that Cynata has engaged to conduct the study.

 

Where to Get Your Morning Stem Cell News? Top 15 Accounts to Follow on Twitter
In a July 2013 USA Today article, Rem Rieder discusses how Twitter “can function as a conveyor belt for first-rate journalism, bringing to your attention terrific material that you might otherwise never encounter”. He then goes on to point out that Twitter is a news pipeline for more than 200 million active users, often ‘breaking’ news before it’s actually news. In this article, you’ll learn the top 15 accounts to follow on Twitter to have breaking stem cell news delivered to your Twitter feed.

 

Future Directions for Induced Pluripotent Stem Cell Research, by an iPSC Scientist
The discovery that we can induce plasticity in formerly fully differentiated cells is one of the greatest inventions of the last decades. In this article, Kevin Bielec, a Scientist at RheinCell Therapeutics GmbH, explores a several aspects that should be considered as future directions for iPSC-related research and development. RheinCell is a Düsseldorf-based company that specializes in research-grade production and characterization of human induced pluripotent stem cells (iPSC).

 

Mesenchymal Stem Cells – Advances & Applications
Recently released, this 250-page global strategic report explores current and future opportunities for mesenchymal stem cells (MSCs). Importantly, it considers traditional market intelligence metrics (grant rates, patent rates, scientific publication rates, clinical trial rates, and more), as well as never released before social analytics (public user data from social media platforms, search engines, Google Trends, and more). Claim cutting-edge data that will improve your strategic decision-making, enhance your commercial strategies, and derive more revenue from MSC-related opportunities.

*Free Bonus: Claim this global strategic report by Fri, Nov. 20, 2015, and we will ship you a free hard copy of the report (value of $200). No code required if you act by Nov. 20, 2015.


 

Click here to view all recently released blog posts or here to view BioInformant’s global strategic reports for the stem cell and cord blood industry.  Be great!

[Read more…]

Filed Under: Adipose SCs, Cord Blood, HSCs, iPS Cells, MSCs, Neural Stem Cells, Stem Cells Tagged With: cord blood, cynata therapeutics, induced pluripotent stem cells, market research, stem cells, twitter

Mesenchymal Stem Cell Industry News Round Up | October 2015

October 14, 2015 By Cade Hildreth (CEO) Leave a Comment

MESENCHYMAL STEM CELL INDUSTRY NEWS ROUND UP | OCTOBER 2015

The mesenchymal stem cell (MSC) industry is well-known for its shifting dynamics, including new alliances, new research advances and innovations. Every month there are major new events that affect market participants.

Therefore, we are excited to share with you the following summary of major mesenchymal stem cell (MSC) industry events for  October 2015.

[Read more…]

Filed Under: MSCs Tagged With: current events, industry news, market research, mesenchymal stem cells, MSC, news round up, stem cell research

  • « Previous Page
  • 1
  • …
  • 3
  • 4
  • 5
  • 6
  • 7
  • …
  • 10
  • Next Page »

Nanocellect

Marathon Products

Let’s Get Social

  • Facebook
  • Twitter
  • LinkedIn
  • Pinterest
  • Instagram
Menu
  • Blog
  • Stem Cell News
    • Press Releases
  • Stem Cells
    • HSCs
    • iPS Cells
    • MSCs
    • Neural Stem Cells
    • Adipose SCs
  • Exosomes
  • Cell Therapy
    • CAR-T
  • Cord Blood
  • Interviews

Cart

Top Rated Products

  • Job Posting on BioInformant Job Posting on BioInformant.com - Your Perfect Hire Is In Our Audience
    Rated 0 out of 5
    $297
  • U.S. Cord Blood Banking Survey Cord Blood Banking Survey of U.S. Parents [2017]
    Rated 0 out of 5
    $197
  • Exosome Companies 2020 Global Database of Exosome Companies
    Rated 0 out of 5
    $149 $97
My Tweets

BioInformant's World-Class Clients

  • Submit Press Release
  • Advertise
  • Privacy and Terms

Copyright © 2022 · BIOINFORMANT, Your Global Leader in Stem Cell Market Research

| Email: Info@BioInformant.com | Phone: 703-859-7617 |

800 Corporate Drive, Suite 301, Stafford, VA 22554, United States

Disclaimer: All statements made on this website are NOT expressed as medical claims or advice. They are not intended to diagnose, treat, cure or prevent any disease or condition. If you have a health condition or concern, consult your physician or health care provider.